{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:37:53Z","timestamp":1776422273219,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T00:00:00Z","timestamp":1304640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11255-011-9980-3","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T09:22:37Z","timestamp":1304587357000},"page":"19-27","source":"Crossref","is-referenced-by-count":14,"title":["Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment"],"prefix":"10.1007","volume":"44","author":[{"given":"Sinan","family":"Ekici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melahat","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcven","family":"Turan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra Erg\u00fcn","family":"Al\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,6]]},"reference":[{"key":"9980_CR1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1464-410x.2000.00576.x","volume":"85","author":"M Aron","year":"2000","unstructured":"Aron M, Rajeev TP, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682\u2013685","journal-title":"BJU Int"},{"key":"9980_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0090-4295(98)00296-9","volume":"52","author":"DA Kapoor","year":"1998","unstructured":"Kapoor DA, Klimberg IW, Malek GH et al (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52:552\u2013558","journal-title":"Urology"},{"key":"9980_CR3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.juro.2008.09.020","volume":"181","author":"S Baltaci","year":"2009","unstructured":"Baltaci S, S\u00fcer E, Halilo\u011flu AH et al (2009) Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. J Urol 181:128\u2013132","journal-title":"J Urol"},{"key":"9980_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0022-5347(01)62107-4","volume":"161","author":"J Gilad","year":"1999","unstructured":"Gilad J, Borer A, Maimon N et al (1999) Failure of ciprofloxacin prophylaxis for ultrasound guided transrectal prostatic biopsy in the era of multiresistant enterobacteriaceae. J Urol 161:222\u2013224","journal-title":"J Urol"},{"key":"9980_CR5","volume-title":"Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement, M100\u2013S19. CLSI","author":"Laboratory Clinical Standards Institute","year":"2009","unstructured":"Laboratory Clinical Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement, M100\u2013S19. CLSI. Wayne, PA, USA"},{"key":"9980_CR6","doi-asserted-by":"crossref","first-page":"S1321","DOI":"10.1093\/clinids\/11.Supplement_5.S1321","volume":"11","author":"KG Naber","year":"1989","unstructured":"Naber KG (1989) Use of quinolones in urinary tract infections and prostatitis. Rev Infect Dis 11:S1321\u2013S1327","journal-title":"Rev Infect Dis"},{"key":"9980_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1464-410X.2007.06848.x","volume":"100","author":"AJ Schaeffer","year":"2007","unstructured":"Schaeffer AJ, Montorsi F, Scattoni V et al (2007) Comparison of a 3-day with 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int 100:51\u201357","journal-title":"BJU Int"},{"key":"9980_CR8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2006.05.003","volume":"50","author":"S Lindstedt","year":"2006","unstructured":"Lindstedt S, Lindstr\u00f6m U, Ljunggren E et al (2006) Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors. Eur Urol 50:832\u2013837","journal-title":"Eur Urol"},{"key":"9980_CR9","unstructured":"Grabe M, Bjerklund-Johansen TE, Botto H, et al. (2010) EAU guidelines on the management of urinary and male genital tract infections; available at: http:\/\/www.uroweb.org\/professional-resources\/guidelines . Accessed Oct 21"},{"key":"9980_CR10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","volume":"179","author":"JS Wolf Jr","year":"2008","unstructured":"Wolf JS Jr, Bennett CJ, Dmochowski R et al (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379\u20131390","journal-title":"J Urol"},{"key":"9980_CR11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dki344","volume":"56","author":"H Arslan","year":"2005","unstructured":"Arslan H, Azap OK, Ergonul O et al (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from communityacquired urinary tract infections in Turkey. J Antimicrob Chemother 56:914\u2013918","journal-title":"J Antimicrob Chemother"},{"key":"9980_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1179\/joc.2009.21.4.383","volume":"21","author":"D Gur","year":"2009","unstructured":"Gur D, Hascelik G, Aydin N et al (2009) Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007. J Chemother 21:383\u2013389","journal-title":"J Chemother"},{"key":"9980_CR13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","volume":"179","author":"J Feliciano","year":"2008","unstructured":"Feliciano J, Teper E, Ferrandino M et al (2008) The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 179:952\u2013955","journal-title":"J Urol"},{"key":"9980_CR14","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/01.ju.0000061280.23447.29","volume":"169","author":"R Tal","year":"2003","unstructured":"Tal R, Livne P, Lask D et al (2003) Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 169:1762\u20131765","journal-title":"J Urol"},{"key":"9980_CR15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/502312","volume":"25","author":"Z Otrock","year":"2004","unstructured":"Otrock Z, Oghlakian G, Salamoun M et al (2004) Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Infect Control Hosp Epidemiol 25:873\u2013877","journal-title":"Infect Control Hosp Epidemiol"},{"key":"9980_CR16","first-page":"2352","volume":"11","author":"S Binsaleh","year":"2004","unstructured":"Binsaleh S, Al-Assiri M, Aronson S et al (2004) Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting? Can J Urol 11:2352\u20132353","journal-title":"Can J Urol"},{"key":"9980_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.euus.2004.06.003","volume":"2","author":"FME Wagenlehner","year":"2004","unstructured":"Wagenlehner FME, Naber KG (2004) Antibiotics and resistance of uropathogens. EAU Update Series 2:125\u2013135","journal-title":"EAU Update Series"},{"key":"9980_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","volume":"51","author":"G Kahlmeter","year":"2003","unstructured":"Kahlmeter G (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO\u00b7SENS Project. J Antimicrob Chemother 51:69\u201376","journal-title":"J Antimicrob Chemother"},{"key":"9980_CR19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1469-0691.2004.01057.x","volume":"11","author":"JI Alos","year":"2005","unstructured":"Alos JI, Serrano MG, Gomez-Garces JL et al (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 11:199\u2013203","journal-title":"Clin Microbiol Infect"},{"key":"9980_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0924-8579(02)00252-2","volume":"20","author":"S Canbaz","year":"2002","unstructured":"Canbaz S, Peksen Y, Sunter AT et al (2002) Antibiotic prescribing and urinary tract infection. Int J Antimicrob Agents 20:407\u2013411","journal-title":"Int J Antimicrob Agents"},{"key":"9980_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00005392-199501000-00040","volume":"153","author":"J Ena","year":"1995","unstructured":"Ena J, Amador C, Martinez C et al (1995) Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 153:117\u2013120","journal-title":"J Urol"},{"key":"9980_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10156-007-0570-3","volume":"14","author":"K Shigehara","year":"2008","unstructured":"Shigehara K, Miyagi T, Nakashima T et al (2008) Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 14:40\u201343","journal-title":"J Infect Chemother"},{"key":"9980_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/49.1.55","volume":"49","author":"JP Horcajada","year":"2002","unstructured":"Horcajada JP, Vila J, Moreno-Martinez A et al (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55\u201359","journal-title":"J Antimicrob Chemother"},{"key":"9980_CR24","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/AAC.49.8.3523-3525.2005","volume":"49","author":"L Poirel","year":"2005","unstructured":"Poirel L, Rodriguez-Martinez JM, Mammeri H et al (2005) Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 49:3523\u20133525","journal-title":"Antimicrob Agents Chemother"},{"key":"9980_CR25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.urology.2009.06.061","volume":"74","author":"JP Horcajada","year":"2009","unstructured":"Horcajada JP, Busto M, Grau S et al (2009) High prevalance of beta-lactamase-producing Enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol. Urology 74:1195\u20131199","journal-title":"Urology"},{"key":"9980_CR26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.diagmicrobio.2007.06.016","volume":"59","author":"V Korten","year":"2007","unstructured":"Korten V, Ulusoy S, Zarakolu P et al (2007) Turkish MYSTIC Study Group. Antibiotic resistance surveillance over a 4-year period (2000\u20132003) in Turkey: results of the MYSTIC Program. Diagn Microbiol Infect Dis 59:453\u2013457","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9980_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2008.12.067","volume":"74","author":"E \u00d6zden","year":"2009","unstructured":"\u00d6zden E, Bostanci Y, Yakupoglu KY et al (2009) Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 74:119\u2013124","journal-title":"Urology"},{"key":"9980_CR28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diagmicrobio.2007.09.006","volume":"60","author":"PJ Turner","year":"2008","unstructured":"Turner PJ (2008) Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis 60:185\u2013192","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9980_CR29","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.urology.2006.08.1075","volume":"68","author":"J Ena","year":"2006","unstructured":"Ena J, Arjona F, Mart\u00ednez-Peinado C et al (2006) Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 68:1169\u20131174","journal-title":"Urology"},{"key":"9980_CR30","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2165\/00003495-200363200-00001","volume":"63","author":"M Kollef","year":"2003","unstructured":"Kollef M (2003) Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 63:2157\u20132168","journal-title":"Drugs"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-011-9980-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-011-9980-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-011-9980-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:59:03Z","timestamp":1559375943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-011-9980-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9980"],"URL":"https:\/\/doi.org\/10.1007\/s11255-011-9980-3","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,6]]}}}